Abstract

ICU-acquired weakness is the most common neuromuscular injury in critically ill patients and an important issue that affects their long-term quality of life. Although ICU-acquired weakness has received increasing attention in recent years, there is still no consensus on its pathophysiological mechanisms, and there are knowledge gaps in identifying high-risk patients and subsequent treatment. This article summarizes the research on ICU-acquired weakness in terms of pathophysiological mechanisms, diagnostic methods, and treatment through a literature review.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call